JTB:: A novel membrane protein gene at 1q21 rearranged in a jumping translocation

被引:41
作者
Hatakeyama, S
Osawa, M
Omine, M
Ishikawa, F
机构
[1] Tokyo Inst Technol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan
[2] Kirin Pharmaceut Res Lab, Takasaki, Gumma 3701202, Japan
[3] Showa Univ, Fujigaoka Hosp, Div Hematol, Aoba Ku, Yokohama, Kanagawa 2270043, Japan
基金
日本学术振兴会;
关键词
jumping translocation; JTB; leukemia;
D O I
10.1038/sj.onc.1202510
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1q21 is frequently involved in different types of translocation in many types of cancers. Jumping translocation (JT) is an unbalanced translocation that comprises amplified chromosomal segments jumping to various telomeres. In this study, we identified a novel gene human JTB (Jumping Translocation Breakpoint) at 1q21, which fused with the telomeric repeats of acceptor telomeres in a case of JT. hJTB (human JTB) encodes a trans-membrane protein that is highly conserved among divergent eukaryotic species. JT results in a hJTB truncation, which potentially produces an hJTB product devoid of the trans-membrane domain. hJTB is located in a gene-rich region at 1q21, called EDC (Epidermal Differentiation Complex). This is the first report identifying the gene involved in unbalanced translocations at 1q21.
引用
收藏
页码:2085 / 2090
页数:6
相关论文
共 17 条
[1]   Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization [J].
Armengol, G ;
Tarkkanen, M ;
Virolainen, M ;
Forus, A ;
Valle, J ;
Bohling, T ;
AskoSeljavaara, S ;
Blomqvist, C ;
Elomaa, I ;
Karaharju, E ;
Kivioja, AH ;
Siimes, MA ;
Tukiainen, E ;
Caballin, MR ;
Myklebost, O ;
Knuutila, S .
BRITISH JOURNAL OF CANCER, 1997, 75 (10) :1403-1409
[2]   CYTOGENETIC STUDIES OF BURKITT-LYMPHOMA - LEUKEMIA IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
BERNHEIM, A ;
BERGER, R .
CANCER GENETICS AND CYTOGENETICS, 1988, 32 (01) :67-74
[3]   The relationship between chromosome structure and function at a human telomeric region [J].
Flint, J ;
Thomas, K ;
Micklem, G ;
Raynham, H ;
Clark, K ;
Doggett, NA ;
King, A ;
Higgs, DR .
NATURE GENETICS, 1997, 15 (03) :252-257
[4]  
Gronwald J, 1997, CANCER RES, V57, P481
[5]   STRINGENT SEQUENCE REQUIREMENTS FOR THE FORMATION OF HUMAN TELOMERES [J].
HANISH, JP ;
YANOWITZ, JL ;
DELANGE, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8861-8865
[6]   Shortened telomeres involved in a case with a jumping translocation at 1q21 [J].
Hatakeyama, S ;
Fujita, K ;
Mori, H ;
Omine, M ;
Ishikawa, F .
BLOOD, 1998, 91 (05) :1514-1519
[7]   Telomere crisis, the driving force in cancer cell evolution [J].
Ishikawa, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 230 (01) :1-6
[8]   High-resolution YAC fragmentation map of 1q21 [J].
Lioumi, M ;
Olavesen, MG ;
Nizetic, D ;
Ragoussis, J .
GENOMICS, 1998, 49 (02) :200-208
[9]   Genetic analysis of the epidermal differentiation complex (EDC) on human chromosome 1q21: Chromosomal orientation, new markers, and a 6-Mb YAC contig [J].
Marenholz, I ;
Volz, A ;
Ziegler, A ;
Davies, A ;
Ragoussis, I ;
Korge, BP ;
Mischke, D .
GENOMICS, 1996, 37 (03) :295-302
[10]  
OFFIT K, 1991, BLOOD, V77, P1508